Noam Zelcer

11.0k citations

95 papers · 8.6k indexed · 5 hit papers · h-index 43

Impact in

Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
Surgery top 0.5%
- Cholesterol and Lipid Metabolism
- Lipoproteins and Cardiovascular Health

Papers in

Biochemistry 13
- Lipid metabolism and biosynthesis 12
Oncology 35
- Drug Transport and Resistance Mechanisms 33

Co-authors: Piet Borst Peter Tontonoz Glen Reid Cynthia Hong Peter R. Wielinga Annemieke Kuil Rima Boyadjian Jan Wijnholds
Journals: Journal of Biological Chemistry (8 papers)Atherosclerosis (6 papers)Molecular and Cellular Biology (5 papers)Nature Communications (4 papers)Current Opinion in Lipidology (4 papers)
Partner nations: Netherlands United States Belgium

In The Last Decade

Noam Zelcer

93 papers receiving 8.5k citations

Hit Papers

5 papers align trajectories log scale

LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor 2009 · 627 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Science
2009 Immunity
2008 Cell
2008 Neuron
2006 Journal of Clinical Investigation

Peers

Countries citing papers authored by Noam Zelcer

Since Specialization

Citations

This map shows the geographic impact of Noam Zelcer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noam Zelcer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noam Zelcer more than expected).

Fields of papers citing papers by Noam Zelcer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noam Zelcer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noam Zelcer. The network helps show where Noam Zelcer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Noam Zelcer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Noam Zelcer Line = papers co-authored together Noam Zelcer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation Nature Communications ·Melanie Loix, Sam Vanherle, Pauschardt, Sanne G. S. Verberk, Qichao Wang, Franco Verdessi, 早山登世美, Sungwhee Shin, Reddymalla Sai Kumar Reddy, Aldo Jongejan, Ben Distel, Ype Elgersma, Mansour Haidar, Noam Zelcer, Jerome J. A. Hendriks, Jeroen F. J. Bogie	2025	1
2	Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia Cellular and Molecular Immunology ·Rizal Tanzil Afgani, A. Kumar, YU.I. KOROVIN, Gaspard Cretenet, Brunella Veloso Dalapicula, Bauke V. Schomakers, Michel van Weeghel, 愛彦国里, Sanne G. S. Verberk, Jan Van den Bossche, Mirjam Langeveld, Fleur S. Kleijwegt, Eric Eldering, Noam Zelcer, Arnon P. Kater, Helga Simon‐Molas	2025	4
3	Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans Nature Communications ·Analía Jacob, Ιωάννης Κλαψόπουλος, Roelof Ottenhoff, Олена Пелешенко, Monika Svecla, Thomas van Pelt, Vinay Sachdev, عاليه محمد الخياط, Johannes H.M. Levels, Aldo Jongejan, Jan Freark de Boer, Folkert Kuipers, Antoine Rimbert, Giuseppe Danilo Norata, Anke Loregger, Noam Zelcer	2023	23
4	The ubiquitous role of ubiquitination in lipid metabolism Trends in Cell Biology ·Melanie Loix, Noam Zelcer, Jeroen F. J. Bogie, Jerome J. A. Hendriks	2023	34
5	Liver X receptor α suppresses SNAI2 ensuring blood‐brain barrier function Alzheimer s & Dementia ·Letitia E. Obeng, Wang Zhan-gou, Inge A. Mulder, Ruud D. Fontijn, Bert van het Hof, Tuti Nur, Gijs Kooij, Annemieke J.M. Rozemüller, Noam Zelcer, Helga E. de Vries, Nienke M. de Wit	2023	1
6	Sterol-regulated transmembrane protein TMEM86a couples LXR signaling to regulation of lysoplasmalogens in macrophages Journal of Lipid Research ·Reddymalla Sai Kumar Reddy, Marlene van den Berg, Murat Orunkhanov, Z. Vecsey, Ιωάννης Κλαψόπουλος, Roelof Ottenhoff, Melanie Loix, Marten A. Hoeksema, Koen H.M. Prange, Gerard Pasterkamp, Jerome J. A. Hendriks, Jeroen F. J. Bogie, Jan B. van Klinken, Frédéric M. Vaz, Aldo Jongejan, Menno P.J. de Winther, Noam Zelcer	2022	7
7	The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and Angiogenic Sprouting Cell Reports ·زينب الحاج مديح جبارة النعيمي, Miesje M. van der Stoel, Marlene van den Berg, Maria-Cristina Andrei, Martina Moeton, Kamuran Aksoy, Nicole N. van der Wel, Igor Kovačević, Peter L. Hordijk, Anke Loregger, Stephan Huveneers, Noam Zelcer	2020	19
8	Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease Molecular Nutrition & Food Research ·Antwi‐Boasiako Oteng, Anke Loregger, Michel van Weeghel, Noam Zelcer, Sander Kersten	2019	36
9	Inactivation of the E3 Ubiquitin Ligase IDOL Attenuates Diet-Induced Obesity and Metabolic Dysfunction in Mice Arteriosclerosis Thrombosis and Vascular Biology ·Maria-Cristina Andrei, Roelof Ottenhoff, Sander Kooijman, Martina Moeton, Saskia Scheij, Reinout L.P. Roscam Abbing, Marion J. Gijbels, Johannes H.M. Levels, Vincenzo Sorrentino, Jimmy F.P. Berbée, Patrick C.N. Rensen, Noam Zelcer	2018	22
10	Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis Atherosclerosis ·زينب الحاج مديح جبارة النعيمي, Emma C. L. Cook, Marlene van den Berg, Saskia Scheij, Noam Zelcer, Anke Loregger	2018	33
11	The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans Journal of Clinical Investigation ·Daphna Weissglas‐Volkov, Anna C. Calkin, Teresa Tusié‐Luna, Janet S. Sinsheimer, Noam Zelcer, Laura Riba, Minami Masaaki, María Luisa Ordóñez-Sánchez, Ivette Cruz‐Bautista, Carlos A. Aguilar‐Salinas, Peter Tontonoz, Päivi Pajukanta	2011	51
12	The E3 Ubiquitin Ligase IDOL Induces the Degradation of the Low Density Lipoprotein Receptor Family Members VLDLR and ApoER2 Journal of Biological Chemistry ·Cynthia Hong, Alice Croq, J. Escher-Desrivières, Ruud Out, 眞吾久田, Vincenzo Sorrentino, Rima Boyadjian, Kees W. Rodenburg, Edan Foley, Laura Korhonen, Dan Lindholm, Johannes Nimpf, Theo J.C. van Berkel, Peter Tontonoz, Noam Zelcer	2010	109
13	LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor Science ·Noam Zelcer, Cynthia Hong, Rima Boyadjian, Peter Tontonoz Hit paper breakdown →	2009	627
14	Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors Proceedings of the National Academy of Sciences ·Noam Zelcer, Négar Khanlou, P. Borecka, Qingguang Jiang, Erin G. Reed-Geaghan, Gary E. Landreth, Harry V. Vinters, Peter Tontonoz	2007	291
15	Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides Journal of Hepatology ·Noam Zelcer, Koen van de Wetering, Rudi de Waart, George L. Scheffer, Hanns–Ulrich Marschall, Peter R. Wielinga, Annemieke Kuil, Cindy Kunne, Alexander J. Smith, Martin van der Valk, Jan Wijnholds, Ronald Oude Elferink, Piet Borst	2005	138
16	Altered Disposition of Acetaminophen in Mice With a Disruption of the Mrp3 Gene * # Hepatology ·José E. Manautou, Dirk R. de Waart, Cindy Kunne, Noam Zelcer, Michael Goedken, Piet Borst, Ronald Oude Elferink	2005	79
17	On the putative co‐transport of drugs by multidrug resistance proteins FEBS Letters ·Piet Borst, Noam Zelcer, Koen van de Wetering, B. Poolman	2005	58
18	Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4) Biochemical Journal ·Noam Zelcer, Glen Reid, Peter R. Wielinga, Annemieke Kuil, Ingrid van der Heijden, John D. Schuetz, Piet Borst	2003	245
19	Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5 Molecular Pharmacology ·Glen Reid, Peter R. Wielinga, Noam Zelcer, Marcel de Haas, Liesbeth van Deemter, Jan Wijnholds, Jan Balzarini, Piet Borst	2003	300
20	Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins Biochemical Pharmacology ·Jeffrey L. Cummings, Noam Zelcer, John Allen, Denggao Yao, Gary W. Boyd, Danilo Pacheco da Silva, Thomas Friedberg, John F. Smyth, Duncan I. Jodrell	2003	56

About Noam Zelcer

Noam Zelcer is a scholar working on Biochemistry, Oncology, Surgery, Cancer Research and Cell Biology, having authored 95 papers that have together received 8.6k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (40 papers), Drug Transport and Resistance Mechanisms (33 papers), Ubiquitin and proteasome pathways (13 papers), Cancer, Lipids, and Metabolism (13 papers), Pharmacological Effects and Toxicity Studies (13 papers), Peroxisome Proliferator-Activated Receptors (12 papers), Lipid metabolism and biosynthesis (12 papers) and Endoplasmic Reticulum Stress and Disease (8 papers). The work is most often cited by research in Oncology (3.2k citations), Surgery (3.1k citations), Cancer Research (1.1k citations), Biochemistry (502 citations) and Pharmacology (562 citations). Noam Zelcer has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Piet Borst, Peter Tontonoz, Glen Reid, Cynthia Hong, Peter R. Wielinga, Annemieke Kuil, Rima Boyadjian, Jan Wijnholds, Jos H. Beijnen and Marcel de Haas. Their work appears in journals such as Journal of Biological Chemistry, Atherosclerosis, Molecular and Cellular Biology, Nature Communications and Current Opinion in Lipidology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact